LAURA LIND: Open Payments
NPI 1811417009 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 19 payments from 4 companies in 2025. Trend: 2023 $251 · 2024 $257 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $178 |
| Insmed, Inc. | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Amgen Inc. | 1 | $28 |
Products named: DUPIXENT, Arikayce, TEZSPIRE.
Industry payments across WA — which companies pay providers there.
